Key facts
- This page summarizes Atlas Venture Opportunity Fund Ill, L.P.'s Form 3 filing for Q32 Bio Inc. (QTTB).
- 0 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 08 Jun 2026, 16:30.
Key filing fact
Ownership activity is grounded in SEC Form 3 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
No transaction description listed
No transaction description listed
No transaction description listed
Additional SEC filing notes
Footnote F1
The shares are owned directly by Atlas Venture Opportunity Fund III, L.P. ("AVOF III"). Atlas Venture Associates Opportunity III, L.P. ("AVAO III LP") is the general partner of AVOF III. Atlas Venture Associates Opportunity III, LLC ("AVAO III LLC") is the general partner of AVAO III LP. Each of AVAO III LP and AVAO III LLC disclaims beneficial ownership of the securities held by AVOF III, except to the extent of its pecuniary interest therein, if any.
SEC remarks
The Reporting Persons are under common control with other entities affiliated with Atlas Venture who, together with the Reporting Persons, collectively beneficially own in the aggregate greater than 10% of the outstanding common stock of the Issuer. The Reporting Persons may be deemed to be members of a "group" with such other entities for purposes of Section 13 of the Exchange Act. However, the Reporting Persons disclaim such group membership, and this Form 3 shall not be deemed an admission that the Reporting Persons are members of a group for purposes of Section 13 of the Exchange Act or for any other purposes.